Literature DB >> 16113812

The role of reverse genetics systems in studying viral hemorrhagic fevers.

Hideki Ebihara1, Allison Groseth, Gabriele Neumann, Yoshihiro Kawaoka, Heinz Feldmann.   

Abstract

Viral hemorrhagic fever (VHF) is an infectious syndrome in humans often associated with high fatality rates. For most VHFs there are no specific and effective therapies or vaccines available and, in general, there is a lack of knowledge regarding the biology and pathogenesis of the causative agents. Therefore, a more detailed understanding of the molecular basis of VHF pathogenesis, including the identification of viral virulence determinants and host interactions and responses, will be important to enhance our ability to control VHF infections. The recently developed "reverse genetics systems" for several VHF causing viruses have allowed the generation of infectious viruses from cloned cDNA and thus, the generation of virus mutants. Here we review the existing reverse genetics systems for VHF causing viruses and discuss their use in studying viral replication, pathogenesis, and the development of antivirals and vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113812     DOI: 10.1160/TH05-05-0335

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.

Authors:  Eric Bergeron; César G Albariño; Marina L Khristova; Stuart T Nichol
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

2.  An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.

Authors:  Yoshimi Tsuda; Thomas Hoenen; Logan Banadyga; Carla Weisend; Stacy M Ricklefs; Stephen F Porcella; Hideki Ebihara
Journal:  J Infect Dis       Date:  2015-03-24       Impact factor: 5.226

3.  Development of a reverse genetics system to generate recombinant Marburg virus derived from a bat isolate.

Authors:  César G Albariño; Luke S Uebelhoer; Joel P Vincent; Marina L Khristova; Ayan K Chakrabarti; Anita McElroy; Stuart T Nichol; Jonathan S Towner
Journal:  Virology       Date:  2013-09-05       Impact factor: 3.616

Review 4.  Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.

Authors:  Thomas Hoenen; Allison Groseth; Fabian de Kok-Mercado; Jens H Kuhn; Victoria Wahl-Jensen
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

5.  Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.

Authors:  Mohamad Hesam Shahrajabian; Wenli Sun; Qi Cheng
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

Review 6.  The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.

Authors:  Osvaldo Martinez; Lawrence W Leung; Christopher F Basler
Journal:  Antiviral Res       Date:  2012-02-08       Impact factor: 5.970

7.  Molecular determinants of Ebola virus virulence in mice.

Authors:  Hideki Ebihara; Ayato Takada; Darwyn Kobasa; Steven Jones; Gabriele Neumann; Steven Theriault; Mike Bray; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

8.  Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination.

Authors:  Aidan M Nikiforuk; Anders Leung; Bradley W M Cook; Deborah A Court; Darwyn Kobasa; Steven S Theriault
Journal:  J Virol Methods       Date:  2016-07-25       Impact factor: 2.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.